Neurocrine Biosciences
NBIX
#1348
Rank
A$21.21 B
Marketcap
$209.57
Share price
5.11%
Change (1 day)
16.76%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Net assets

Net assets on the balance sheet as of September 2024 : A$4.27 Billion

According to Neurocrine Biosciences 's latest financial reports the company has A$4.27 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Neurocrine Biosciences - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$A$3.27 B30.54%
2022-12-31$A$2.50 B32.42%
2021-12-31$A$1.89 B29.4%
2020-12-31$A$1.46 B61.01%
2019-12-31$A$0.90 B33.3%
2018-12-31$A$0.68 B43.17%
2017-12-31$A$0.47 B9.12%
2016-12-31$A$0.43 B-25.03%
2015-12-31$A$0.58 B128.48%
2014-12-31$A$0.25 B88.91%
2013-12-31$A$0.13 B-9.13%
2012-12-31$A$0.14 B153.51%
2011-12-31$A$58.59 M207.68%
2010-12-31$A$19.04 M332.67%
2009-12-31$A$4.4 M-91.56%
2008-12-31$A$52.12 M-61.61%
2007-12-31$A$0.13 B-65.99%
2006-12-31$A$0.39 B-25.12%
2005-12-31$A$0.53 B4.76%
2004-12-31$A$0.50 B-3.28%
2003-12-31$A$0.52 B32.2%
2002-12-31$A$0.39 B-34.55%
2001-12-31$A$0.60 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
A$3.17 B-25.83%๐Ÿ‡บ๐Ÿ‡ธ USA
A$16.14 B 277.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
-A$12.1 Million-100.28%๐Ÿ‡บ๐Ÿ‡ธ USA
A$22.53 B 426.71%๐Ÿ‡บ๐Ÿ‡ธ USA
A$9.55 B 123.29%๐Ÿ‡บ๐Ÿ‡ธ USA
A$145.64 B 3,304.24%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.67 B-84.16%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$57.28 Million-101.34%๐Ÿ‡บ๐Ÿ‡ธ USA